IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...
IQVIA Holdings Inc. (NYSE:IQV), a global leader in advanced analytics, technology solutions, and clinical research services for the healthcare and life sciences industries, finds itself at a critical ...
BTIG analyst David Larsen downgraded Iqvia (IQV) to Neutral from Buy without a price target The firm says clinical research organization ...
Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions. Surbhi Jain Elliott Investment Management Adds To Southwest, Western Digital ...
While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX – Research Report), Amgen (AMGN – ...
Evaluate the expected performance of IQVIA (IQV) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics ...
IQVIA Holdings Inc. closed 20.91% below its 52-week high of $261.73, which the company reached on March 8th.
Barclays lowered the firm’s price target on Iqvia (IQV) to $235 from $255 and keeps an Overweight rating on the shares. The firm says the life ...